Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2026-05-23 @ 12:25 PM
Study NCT ID:
NCT00401804
Status:
COMPLETED
Last Update Posted:
2013-01-24
First Post:
2006-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bortezomib-Dexamethasone-Doxorubicin-Study
Sponsor:
Austrian Forum Against Cancer
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Eudract Number: 2005-003001-85
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None